
EnsoData Snags $20M to Improve Sleep Disorder Diagnostics
EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently.
EnsoData raised $20 million in Series B funds for its AI-powered sleep diagnostics. The company’s technology aims to help clinicians diagnose sleep disorders faster and more consistently.
Health system performance has splintered into three distinct groups — leaders, strugglers and those stuck in the middle, according to Fitch Ratings’ Kevin Holloran. At the HFMA Annual Conference, he and Mayo Clinic CFO Dennis Dahlen discussed how technology and innovation are accelerating this divide.
At the HFMA Annual Conference, AI expert Zack Kass shared a personal story to emphasize the enduring importance of human qualities like empathy and compassion in healthcare. In his view, these qualities will only become more essential as AI continues to transform the clinical landscape.
Intermountain Health is deploying Layer Health’s AI engine for clinical data abstraction across several of its patient registries. The health system’s venture capital arm is also making a strategic investment in the startup.
Over the past couple of years, ambient scribes have earned widespread adoption among health systems. While there's excitement around other categories like AI agents, no other AI use case has achieved ambient scribes’ level of traction, noted Daniel Yang, Kaiser Permanente’s vice president of AI and emerging technologies.
Providers need a revenue cycle management platform that is more affordable and accurate, said Jeremy Delinsky, CEO of Smarter Technologies, during MedCity News’ INVEST conference. New Mountain Capital formed Smarter Technologies this week by combining three separate platforms it had already acquired.
To scale clinical AI, vendors must design tools that feel natural and personalized to each doctor — otherwise, clinicians won’t use them, said Heidi Health CEO Tom Kelly. In the crowded AI scribe market, he believes that clinician adoption rates, not flashy integration or deployment speeds, are the true measure of success.
Ensuring buy-in from end users is critical to hospitals’ AI success. To achieve buy-in, hospitals should start by adopting AI tools that address the problems that physicians and nurses have identified as most important to them, said Rohit Chandra, chief digital officer at Cleveland Clinic.
Without trust, the rapid adoption of AI in healthcare could stall, pointed out Joel Gordon, UW Health’s chief medical information officer. He urged healthcare leaders to focus less on flashy rollouts and more on governance, collaboration, and meaningful metrics to ensure AI delivers lasting value.
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners.
Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders feel at least somewhat confident in their organization’s AI governance frameworks, but only 15% report having scalable infrastructure in place.
OhioHealth is scaling its use of Digital Diagnostics’ AI system that autonomously diagnoses diabetic retinopathy during primary care visits.
Andy Crowder, chief digital officer at Advocate Health, detailed five benefits his health system is experiencing as a result of being bullish on AI — including better staff retention, clinical improvements and cost savings.
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models.